Table 1 Values shown are mean (SD) or ageometric mean (± 1 SD range)
From: Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation
| Â | Placebo (n = 13) | 1.25 mg (n = 29) | 2.5 mg (n = 28) |
|---|---|---|---|
Age (yrs) | 68.3 (6.0) | 66.5 (7.0) | 64.0 (6.7) |
YSM (yrs) | 20 (6.2) | 19.6 (6.1) | 17.5 (6.5) |
Height (cm) | 158.5 (5.3) | 159.7 (5.9) | 162.9 (6.1) |
Weight (kg) | 61.8 (6.8) | 62.5 (9.5) | 61.1 (6.8) |
BMI (kg/m2) | 24.7 (3.2) | 24.5 (3.4) | 23.1 (2.8) |
aCTXI (μg/mmol) | 0.26 (0.18–0.37) | 0.32 (0.21–0.49) | 0.31 (0.22–0.45) |
aCTXII (μg/mmol) | 0.13 (0.08–0.26) | 0.17 (0.09–0.32) | 0.13 (0.07–0.24) |